RxDoctor Payments Data

Wilfred Miller, DO

Family Medicine · Midlothian, TXNPI 1073599205

Payments from drug & device makers

$1,322in general payments, 2019–2025

Across 76 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$368
  • Novo Nordisk$227
  • AbbVie$185
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$125
  • Takeda Pharmaceuticals U.S.A., Inc.$123
  • Amgen$60
  • plus $235 from 9 others

What the payments were for

  • Food & beverage$1,322100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,322 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$46,390
Medicare patients
101
Services billed
6,379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$57,944
OzempicSemaglutide38$52,375
RelistorMethylnaltrexone Bromide12$33,177
RybelsusSemaglutide13$29,266
MounjaroTirzepatide22$23,366
TrulicityDulaglutide11$13,002
XareltoRivaroxaban22$12,388
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$11,245
SymbicortBudesonide/Formoterol Fumarate19$10,808
Albuterol Sulfate HfaAlbuterol Sulfate73$2,975
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen100$2,890
Dexlansoprazole DrDexlansoprazole13$2,083
Gabapentin83$2,039
SynthroidLevothyroxine Sodium21$1,323
Levothyroxine Sodium148$984

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$227$81,64051 claims
Lilly USA, LLCMounjaro, Trulicity$368$36,36833 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$125$33,17712 claims
GSKTrelegy Ellipta$38$11,24511 claims
AbbVieSynthroid$185$1,32321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Midlothian

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →